Non‐overlapping American College of Rheumatology response rates: A better way to report response in rheumatoid arthritis Clinical Trials

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|62|12|3524-3527

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3524-3527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Relationship between response rates and median progression‐free survival in non‐Hodgkin's lymphoma: A meta‐analysis of published clinical trials

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 37-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimation of Multiple Response Rates in Phase II Clinical Trials with Missing Observations

By Chang Myron  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 5, 2009-09 ,pp. : 791-802

Taylor & Francis Ltd

Access to resources Recommend Favorite

Durability and Rapidity of Response to Anakinra in Patients with Rheumatoid Arthritis

By Michael H. Schiff  

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2493-2501

Adis International

Access to resources Recommend Favorite

Will Pharmacogenetics Predict Response to Therapies in Rheumatoid Arthritis?

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-01 ,pp. : 307-319

Bentham Science Publishers

Access to resources Recommend Favorite

Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 2, 2015-01 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite